恒瑞医药(01276)_个股概要_股票价格_最新资讯_行情走势_历史数据 - 老虎社区

应交易所要求，美/港股行情延时15分钟展示，下载APP即可免费查看实时行情。

关闭

01276 恒瑞医药

交易中 05-12 10:35:16

67.900

+1.850

+2.80%

最高68.900	最低65.300	成交量253.82万
今开66.150	昨收66.050	日振幅5.45%
总市值4,507亿	流通市值175.18亿	总股本66.37亿
成交额1.71亿	换手率0.98%	流通股本2.58亿
市净率--	ROE--	每股收益0.00
52周最高--	52周最低--	市盈率--
股息--	股息收益率--	ROA--

数据加载中...

北京优虎网络科技有限公司

免责声明:香港交易所资讯服务有限公司、其控股公司及／或该等控股公司的任何附属公司均竭力确保所提供信息的准确和可靠度，但不能保证其绝对准确和可靠，且亦不会承担因任何不准确或遗漏而引起的任何损失或损害的责任（不管是否侵权法下的责任或合约责任又或其它责任）

{"stockData":{"symbol":"01276","market":"HK","secType":"STK","nameCN":"恒瑞医药","latestPrice":67.9,"timestamp":1778553315431,"preClose":66.05,"halted":0,"volume":2538162,"delay":0,"changeRate":0.02800908402725221,"floatShares":258000000,"shares":6637000000,"eps":1.18,"marketStatus":"交易中","change":1.85,"latestTime":"05-12 10:35:16","open":66.15,"high":68.9,"low":65.3,"amount":171204272,"amplitude":0.054504,"askPrice":67.9,"askSize":6400,"bidPrice":67.85,"bidSize":6200,"shortable":3,"etf":0,"ttmEps":1.385,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1778558400000},"marketStatusCode":2,"adr":0,"listingDate":1747929600000,"exchange":"SEHK","adjPreClose":66.05,"dividendRate":0.003373,"openAndCloseTimeList":[[1778549400000,1778558400000],[1778562000000,1778572800000]],"volumeRatio":5.570577,"lotSize":200,"spreadScale":0,"tradeCurrency":"HKD","astockBrief":{"symbol":"600276","market":"SH","secType":"STK","nameCN":"恒瑞医药","latestPrice":53.67,"timestamp":1778553313000,"preClose":53.52,"halted":0,"volume":46896600,"delay":0,"premium":"+9.77"}},"requestUrl":"/m/hq/s/01276","defaultTab":"news","newsList":[{"id":"2634015154","title":"花旗：中国医疗保健行业基本面持续改善 首选药明康德(02359)等","url":"https://stock-news.laohu8.com/highlight/detail?id=2634015154","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634015154?lang=zh_cn&edition=full","pubTime":"2026-05-11 16:54","pubTimestamp":1778489665,"startTime":"0","endTime":"0","summary":"创新正获得回报，授权交易预付款及里程碑付款带动盈利，创新药销售加速，而CXO订单量更创下历史新高。展望未来，该行预期将有一系列短期催化剂，包括ASCO 2026年数据发布、授权交易势头持续、4月14日药品价格改革后续、CXO指引可能上调，以及市场整合加速利好医疗科技、服务及药房领导者。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440195.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0979878070.USD","02359","LU0315179316.USD","LU0516423174.USD","BK1141","LU1366192091.USD","02269","LU1719994722.HKD","LU1951186391.HKD","IE0008369823.USD","SG9999004220.SGD","LU1226287792.SGD","LU1226288253.USD","LU0170899867.USD","BK1515","LU0572944931.SGD","IE00B5MMRT66.SGD","LU1997245177.USD","BK1191","LU1506573853.SGD","LU2125154935.USD","LU0203347892.USD","LU0516422366.SGD","LU2242644610.SGD","LU0314109678.HKD","LU2417539215.USD","IE00B031HY20.USD","LU1023057109.AUD","LU0098860793.USD","LU0326950275.SGD","LU0359202008.SGD","LU0307460666.USD","LU2488822045.USD","LU1008478684.HKD","LU0455707207.USD","LU1997244956.HKD","LU0980610538.SGD","BK4504","IE00BZ08YT58.USD","01276","01801","LU2360032135.SGD","01672","LU0072461881.USD","01093","LU1242518857.USD","LU2045819591.USD","LU2097828714.EUR","LU0310800965.SGD","603259"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634406105","title":"智通AH统计|5月11日","url":"https://stock-news.laohu8.com/highlight/detail?id=2634406105","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634406105?lang=zh_cn&edition=full","pubTime":"2026-05-11 16:15","pubTimestamp":1778487309,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止5月11日收盘，东北电气、浙江世宝、中石化油服分列AH溢价率前三位，溢价率分别为520.69%、351.02%、310.39%；宁德时代、兆易创新、药明康德分列AH溢价率末三位，溢价率分别为-18.73%、-18.00%、-5.71%。其中南华期货股份、晨鸣纸业、山东墨龙的偏离值位居前三，分别为33.64%、31.27%、31.27%；另外，东北电气、中芯国际、中国人寿的偏离值位居后三，分别为-46.24%、-20.47%、-18.81%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1440155.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02691","02768","02628","02338","00470","02701","01800","HPAD.SI","02899","PNGAY","02238","00042","01276","03143","688981","01349","01812","03996","03328","159982","03986","00553","03678","601318","00568","00991","02359","03145","03750","00981","02218","03908","03968","00187","00588","01033","02318","06869","02465","01057","82318","399300","EWH","LU0449515922.USD","LU0797268264.HKD","PAImain","00386","01108","01989"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633579534","title":"沪市主板医药公司首季业绩稳中略升 营收同比增长2%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633579534","media":"新华财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633579534?lang=zh_cn&edition=full","pubTime":"2026-05-08 22:14","pubTimestamp":1778249642,"startTime":"0","endTime":"0","summary":"新华财经上海5月8日电A股一季报披露已收官，沪市主板医药类公司首季整体业绩保持稳中略升。数据显示，沪市主板111家医药类公司2026年一季度合计实现营业收入3305.5亿元，同比增长2%；合计实现净利润247亿元，同比增长0.5%。其中，药明康德、恒瑞医药两家龙头企业分别贡献超过46.5亿元和22.8亿元净利润，均实现营收、净利润较快增长，为板块首季表现提供重要支撑。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605083731846125.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["01276","LU0359202008.SGD","06978","BK1574","LU1023057109.AUD","LU2543165471.USD","600276","LU0359201885.HKD","LU0359201612.USD","BK1161","BK1191"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633432462","title":"恒瑞医药HRS-3005片临床试验获批","url":"https://stock-news.laohu8.com/highlight/detail?id=2633432462","media":"北京商报","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633432462?lang=zh_cn&edition=full","pubTime":"2026-05-08 18:16","pubTimestamp":1778235388,"startTime":"0","endTime":"0","summary":"5月8日，恒瑞医药发布公告称，公司近日收到国家药品监督管理局核准签发关于HRS-3005片的《药物临床试验批准通知书》，将于近期开展临床试验。根据公告，HRS-3005片是恒瑞医药自主研发的创新型抗肿瘤药物，拟用于B细胞恶性肿瘤的治疗，目前国内外暂无同类药物获批上市。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202605083731651317.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605083731651317.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["BK0028","LU1997245094.SGD","LU1580142542.USD","LU2097828714.EUR","LU2328871848.SGD","LU2580892862.HKD","LU1146622755.USD","LU1969619763.USD","LU2580892789.USD","LU0359201612.USD","BK1191","BK0012","LU0359202008.SGD","LU1655091616.SGD","LU1328615791.USD","LU2097828557.USD","600276","LU0359201885.HKD","LU2495084118.USD","LU2543165471.USD","LU1064131003.USD","01276","LU0405327494.USD","BK0183","LU1064130708.USD","LU2097828474.EUR","LU0405327148.USD","BK0239","BK0060","LU1997244956.HKD","LU2488822045.USD","LU1820825898.SGD","LU1023057109.AUD","BK0188","BK0196","LU1781817850.SGD","LU2148510915.USD","LU2097828805.USD","LU1997245177.USD","LU2289578879.USD","LU1255011170.USD","LU2097828631.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633794147","title":"多家药企高管生变：恒瑞、复星、阿斯利康、辉瑞…","url":"https://stock-news.laohu8.com/highlight/detail?id=2633794147","media":"赛柏蓝","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633794147?lang=zh_cn&edition=full","pubTime":"2026-05-07 19:53","pubTimestamp":1778154780,"startTime":"0","endTime":"0","summary":"01本土制药企业与Biotech迎高管变动恒瑞医药、再鼎医药、百济神州、和铂医药、复星医药映射出了中国创新药发展过程中企业所处的不同阶段。4月16日，恒瑞医药发布公告，正式完成新一届董事会和管理层聘任。复星医药4月2日，复星医药发布首席财务官变更公告，因工作安排调整，陈战宇辞去首席财务官职务。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-05-07/doc-inhxatff4708181.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["LU0122379950.USD","02142","LU2417539215.USD","LU2236285917.USD","01276","LU0058720904.USD","LU2237443549.SGD","SG9999002232.USD","600196","LU1066051498.USD","IE00BBT3K403.USD","LU2237443382.USD","600276","LU2237443895.HKD","BK4592","06160","IE00B19Z3581.USD","LU0234572021.USD","LU0456855351.SGD","02196","LU1023059063.AUD","BK4581","LU0109394709.USD","LU1066053197.SGD","LU2462157665.USD","SG9999003800.SGD","IE0002270589.USD","SG9999011175.SGD","SGXZ57979304.SGD","IE000M9KFDE8.USD","SG9999013999.USD","IE00BLSP4239.USD","LU1829250122.USD","LU0321505439.SGD","LU0225284248.USD","BK4534","LU0225771236.USD","LU2237443978.SGD","SG9999002224.SGD","LU2456880835.USD","IE00B19Z3B42.SGD","IE00BLSP4452.SGD","LU0868494617.USD","PFE","SG9999001176.SGD","LU2237443622.USD","BK4568","LU0321505868.SGD","LU0306806265.USD","LU1057294990.SGD","BK4588","LU0306807586.USD","LU2237443465.HKD","ONC","BK4533","LU1883839398.USD","LU1894683348.USD","SG9999001176.USD","LU1894683264.USD","LU0889565916.HKD","688235","LU0170899867.USD","LU0985481810.HKD","LU0320765992.SGD","BK4599","AZNH","BK4007","BK4585","LU0289739699.SGD","AZN","BK4550","IE00B3T34201.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633119513","title":"恒瑞医药已回购1206万股 金额7.72亿元","url":"https://stock-news.laohu8.com/highlight/detail?id=2633119513","media":"财中社","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633119513?lang=zh_cn&edition=full","pubTime":"2026-05-07 16:45","pubTimestamp":1778143500,"startTime":"0","endTime":"0","summary":"5月7日，恒瑞医药（600276/01276）发布公告，截至2026年4月30日已回购1206万股，占总股本的0.18%，回购金额为7.72亿元，回购价格区间为53.52元/股至70元/股。2026年一季度，恒瑞医药实现收入0.0元，归母净利润22.82亿元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202605073730120976.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU2495084118.USD","LU2580892862.HKD","LU0359201885.HKD","BK0196","LU2148510915.USD","LU1820825898.SGD","LU1064130708.USD","BK0060","LU1064131003.USD","LU0405327148.USD","LU1146622755.USD","LU1580142542.USD","LU1969619763.USD","LU2328871848.SGD","LU2097828631.EUR","01276","BK0012","LU1023057109.AUD","LU0405327494.USD","LU2488822045.USD","LU2289578879.USD","BK0028","LU2580892789.USD","LU2097828805.USD","LU2097828557.USD","LU0359201612.USD","LU1328615791.USD","LU1655091616.SGD","LU1997245177.USD","LU2097828714.EUR","LU2543165471.USD","LU1781817850.SGD","600276","BK0239","LU0359202008.SGD","BK0183","LU1997244956.HKD","BK1191","BK0188","LU2097828474.EUR","LU1997245094.SGD","LU1255011170.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633168491","title":"智通AH统计|5月7日","url":"https://stock-news.laohu8.com/highlight/detail?id=2633168491","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633168491?lang=zh_cn&edition=full","pubTime":"2026-05-07 16:27","pubTimestamp":1778142422,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止5月7日收盘，东北电气、浙江世宝、中石化油服分列AH溢价率前三位，溢价率分别为542.86%、352.34%、309.21%；兆易创新、宁德时代、潍柴动力分列AH溢价率末三位，溢价率分别为-19.84%、-16.84%、-5.47%。其中南华期货股份、山东墨龙、国恩科技的偏离值位居前三，分别为30.05%、25.66%、24.46%；另外，广合科技、东北电气、中国人寿的偏离值位居后三，分别为-22.82%、-22.57%、-22.40%。　　前十大AH股溢价率排行。　　股票名称H股(港元)A股溢价率↓偏离值","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260507/32206350.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["02465","82318","02628","06031","01989","BK1539","02238","PNGAY","02318","02701","02768","01057","03143","03678","601318","399300","01349","01033","02865","HPAD.SI","03968","00042","00981","LU0651947912.USD","02899","02359","03908","LU0210527791.USD","09980","02208","02338","159982","02880","03986","00187","02691","01812","00338","EWH","01108","03145","LU0819123356.HKD","00568","00553","PAImain","01171","01276","03750","02218"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172253873","title":"恒瑞医药公布2026年4月股份变动月报表，股本总体维持稳定","url":"https://stock-news.laohu8.com/highlight/detail?id=1172253873","media":"公告速递","labels":["shareholding","SGX"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172253873?lang=zh_cn&edition=full","pubTime":"2026-05-07 16:25","pubTimestamp":1778142347,"startTime":"0","endTime":"0","summary":"江苏恒瑞医药股份有限公司于2026年5月7日发布了截至2026年4月30日的股份变动月报表。公告显示，公司在本月内各类股份法定注册股本无变化，已发行股份总数保持稳定。在股本结构方面，公司普通股包括H股和A股。H股法定/注册股份数为258,197,600股，A股法定/注册股份数为6,379,002,274股，两者面值均为每股人民币1元。公司在本报告期内购回的A股已按计划作为库存股份持有，并未注销。本次月报表由公司联席公司秘书刘笑含提交。","market":"sh","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,SGX","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633907812","title":"智通AH统计|5月6日","url":"https://stock-news.laohu8.com/highlight/detail?id=2633907812","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633907812?lang=zh_cn&edition=full","pubTime":"2026-05-06 16:15","pubTimestamp":1778055307,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止5月6日收盘，东北电气、浙江世宝、中石化油服分列AH溢价率前三位，溢价率分别为566.67%、349.36%、309.09%；兆易创新、宁德时代、潍柴动力分列AH溢价率末三位，溢价率分别为-22.70%、-17.64%、-7.95%。其中可孚医疗、南华期货股份、晨鸣纸业的偏离值位居前三，分别为53.19%、34.22%、33.54%；另外，龙蟠科技、广合科技、中国人寿的偏离值位居后三，分别为-29.45%、-26.26%、-20.24%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438501.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00042","02691","LU0348825331.USD","02865","00553","03678","06127","BK1171","02880","00300","03296","SG9999012710.SGD","03968","00588","02628","09980","IE00B031J352.USD","02218","02465","LU0228367735.SGD","LU0329678170.USD","01057","BK1550","01330","00981","03143","BK1223","LU0329678337.USD","01108","03986","02768","02238","06031","03200","00187","03908","159982","02899","01276","01033","01187","02338","02359","EWH","399300","03750","01812","01989","01349"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633990206","title":"智通AH统计|5月5日","url":"https://stock-news.laohu8.com/highlight/detail?id=2633990206","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633990206?lang=zh_cn&edition=full","pubTime":"2026-05-05 16:15","pubTimestamp":1777968906,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止5月5日收盘，东北电气、浙江世宝、中石化油服分列AH溢价率前三位，溢价率分别为566.67%、339.66%、302.47%；宁德时代、兆易创新、潍柴动力分列AH溢价率末三位，溢价率分别为-20.27%、-19.55%、-13.29%。其中晨鸣纸业、南华期货股份、东鹏饮料的偏离值位居前三，分别为36.07%、32.59%、30.48%；另外，龙蟠科技、广合科技、绿色动力环保的偏离值位居后三，分别为-33.03%、-23.37%、-18.84%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1438072.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02218","LU0417516738.SGD","01057","LU0348825331.USD","02318","601318","LU1981816686.USD","02465","EWH","03908","PAImain","LU1008478684.HKD","LU2097828631.EUR","00042","02238","02338","HPAD.SI","06166","PNGAY","03968","02899","03678","03143","09980","00300","01033","BK1116","06127","03750","00553","01349","03986","02359","03145","01108","02628","01330","00991","02208","399300","01276","00187","02701","01812","01989","02691","159982","82318","03200"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1135325932","title":"花旗集团增持恒瑞医药H股 持股比例从6.68%升至7.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=1135325932","media":"美股速递","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1135325932?lang=zh_cn&edition=full","pubTime":"2026-05-04 18:07","pubTimestamp":1777889223,"startTime":"0","endTime":"0","summary":"根据香港交易所最新披露文件显示，花旗集团对江苏恒瑞医药H股的持股比例出现显著变动。截至4月27日，该机构持有的多头头寸已从原先的6.68%提升至7.48%，增幅达0.8个百分点。\n此次持股比例的上调反映出国际金融机构对中国医药龙头企业的持续看好。作为国内创新药领域的标杆企业，恒瑞医药始终受到全球投资者的密切关注。花旗集团此次增持动作，可能预示着其对该公司长期发展前景的积极预期。\n资本市场专业人士指出，机构投资者持股比例的变动往往被视为重要的市场风向标。此次持股比例突破7%的关键点位，不仅体现了外资对中国医药行业的信心，也可能对二级市场投资情绪产生正向影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":"","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0405327494.USD","LU2097828805.USD","LU2328871848.SGD","LU0359201885.HKD","LU1146622755.USD","LU2488822045.USD","LU2543165471.USD","LU1655091616.SGD","LU2148510915.USD","BK0239","BK0012","LU2097828714.EUR","BK0188","BK0060","LU1255011170.USD","BK0196","LU2097828557.USD","BK0028","LU1064130708.USD","LU1064131003.USD","LU2580892862.HKD","LU1781817850.SGD","LU1997245094.SGD","LU2580892789.USD","LU2097828631.EUR","LU1328615791.USD","LU0359201612.USD","LU1997244956.HKD","LU2495084118.USD","BK1191","LU1969619763.USD","LU1580142542.USD","01276","LU1997245177.USD","LU1023057109.AUD","LU1820825898.SGD","LU2097828474.EUR","600276","LU2289578879.USD","LU0359202008.SGD","BK0183","LU0405327148.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632936002","title":"智通AH统计|5月4日","url":"https://stock-news.laohu8.com/highlight/detail?id=2632936002","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632936002?lang=zh_cn&edition=full","pubTime":"2026-05-04 16:15","pubTimestamp":1777882505,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止5月4日收盘，东北电气、浙江世宝、中石化油服分列AH溢价率前三位，溢价率分别为550.60%、343.48%、297.56%；兆易创新、宁德时代、潍柴动力分列AH溢价率末三位，溢价率分别为-22.35%、-17.30%、-13.73%。其中南华期货股份、晨鸣纸业、国民技术的偏离值位居前三，分别为33.16%、23.33%、18.29%；另外，龙蟠科技、金风科技、广合科技的偏离值位居后三，分别为-27.88%、-24.91%、-21.65%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437827.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["03986","02899","LU0531971595.HKD","HK0000286598.CNH","00553","LU0327786744.USD","02208","03678","01349","06127","01276","02359","02865","03908","00568","02238","02701","01812","00187","00300","LU0082770016.SGD","00981","01989","159982","LU0231483743.USD","06166","BK1505","EWH","02628","02465","02691","LU1152091168.USD","03968","02218","03750","LU0287142896.SGD","06031","399300","01108","01330","03200","00042","03143","09981","LU0797268264.HKD","01033","LU1880383366.USD","01057","02338"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632601701","title":"14款1类新药在中国获批临床！来自长风药业(02652)、恒瑞医药(01276)等","url":"https://stock-news.laohu8.com/highlight/detail?id=2632601701","media":"智通财经网","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632601701?lang=zh_cn&edition=full","pubTime":"2026-05-03 16:39","pubTimestamp":1777797543,"startTime":"0","endTime":"0","summary":"上周(4月27日~5月2日)，有14款1类创新药首次在中国获得临床试验默示许可(IND)。这些产品涵盖小分子、多肽、抗体、抗体偶联药物(ADC)等等。","market":"hk","thumbnail":"https://img.zhitongcaijing.com/image/20260503/20260503163939_45803.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260503/20260503163939_45803.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437677.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["02652","01276","LU2097828631.EUR","LU1820825898.SGD","LU1064131003.USD","BK0012","LU2543165471.USD","LU2328871848.SGD","LU2488822045.USD","LU1580142542.USD","BK0060","BK1191","LU1064130708.USD","LU1969619763.USD","LU2148510915.USD","LU2097828714.EUR","LU0405327148.USD","LU2097828474.EUR","BK0188","BK0196","LU2097828805.USD","LU1655091616.SGD","LU2580892789.USD","LU2580892862.HKD","LU1023057109.AUD","LU1146622755.USD","LU0359201885.HKD","LU1997245177.USD","LU2289578879.USD","LU1255011170.USD","LU1328615791.USD","BK0028","600276","LU1997245094.SGD","LU0359201612.USD","LU0359202008.SGD","LU1997244956.HKD","BK0183","LU1781817850.SGD","LU0405327494.USD","BK0239","LU2495084118.USD","LU2097828557.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631858446","title":"智通AH统计|4月30日","url":"https://stock-news.laohu8.com/highlight/detail?id=2631858446","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631858446?lang=zh_cn&edition=full","pubTime":"2026-04-30 16:15","pubTimestamp":1777536906,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止4月30日收盘，东北电气、浙江世宝、中石化油服分列AH溢价率前三位，溢价率分别为566.67%、349.34%、297.56%；兆易创新、宁德时代、药明康德分列AH溢价率末三位，溢价率分别为-19.44%、-12.70%、-3.51%。其中安德利果汁、南华期货股份、广汽集团的偏离值位居前三，分别为29.55%、29.35%、25.29%；另外，绿色动力环保、龙蟠科技、大族数控的偏离值位居后三，分别为-21.51%、-20.11%、-19.09%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1437179.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["02318","03968","82318","LU1244550494.USD","02465","00568","00638","02333","PNGAY","PAImain","159982","01989","02208","03750","399300","LU0348766576.USD","82333","02359","00553","601633","HPAD.SI","03143","00042","00300","03200","02628","00317","01108","02218","01033","02238","HK0000306685.HKD","03145","EWH","601318","00187","01057","02338","00981","02691","03678","03986","00470","01349","02701","01330","00916","GWLLY","01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630665375","title":"智通AH统计|4月28日","url":"https://stock-news.laohu8.com/highlight/detail?id=2630665375","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630665375?lang=zh_cn&edition=full","pubTime":"2026-04-28 16:15","pubTimestamp":1777364106,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止4月28日收盘，东北电气、浙江世宝、弘业期货分列AH溢价率前三位，溢价率分别为558.54%、427.64%、301.85%；兆易创新、宁德时代、药明康德分列AH溢价率末三位，溢价率分别为-17.27%、-15.66%、-7.45%。其中浙江世宝、晨鸣纸业、龙源电力的偏离值位居前三，分别为96.06%、26.75%、26.70%；另外，绿色动力环保、广合科技、金风科技的偏离值位居后三，分别为-19.54%、-18.15%、-17.49%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1435207.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["00300","01812","02359","02218","00553","01276","02338","01989","02603","03968","399300","03750","LU0164865239.USD","06031","03678","LU2097828631.EUR","02009","IE00B0169L03.USD","LU0266512127.USD","00916","09611","EWH","01033","00317","02691","02899","02465","159982","03996","LU1988902786.USD","09981","01108","03986","03143","00568","03908","00588","LU0320764599.SGD","01349","LU0072913022.USD","00042","02701","01057","BK1193","01330","BK1135","LU0117841782.USD","02208","00470"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630602365","title":"智通AH统计|4月27日","url":"https://stock-news.laohu8.com/highlight/detail?id=2630602365","media":"智通财经网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630602365?lang=zh_cn&edition=full","pubTime":"2026-04-27 16:15","pubTimestamp":1777277705,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，截止4月27日收盘，东北电气、浙江世宝、弘业期货分列AH溢价率前三位，溢价率分别为542.86%、362.20%、301.49%；宁德时代、兆易创新、招商银行分列AH溢价率末三位，溢价率分别为-21.47%、-19.59%、-6.32%。其中龙源电力、浙江世宝、南华期货股份的偏离值位居前三，分别为33.96%、31.22%、24.81%；另外，剑桥科技、金风科技、广和通的偏离值位居后三，分别为-31.05%、-24.84%、-18.55%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434356.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["00916","01033","09981","00553","01108","03750","01330","BK1231","01276","03968","06166","LU2045819591.USD","IE00B3M56506.USD","LU0287142896.SGD","02218","00470","02338","03996","03969","06031","LU0307460666.USD","00042","00568","00386","02701","06680","02899","00588","03143","LU1051768304.USD","00638","02208","BK1105","01057","02359","03678","IE00BVYPNP33.GBP","02603","LU1880383440.USD","03200","03986","01349","LU0149721374.USD","00300","02691","03328","BK1594","LU1328277881.USD","00187"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630368994","title":"交银国际：升恒瑞医药(01276)目标价至74港元 首季业绩延续高增长态势","url":"https://stock-news.laohu8.com/highlight/detail?id=2630368994","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630368994?lang=zh_cn&edition=full","pubTime":"2026-04-27 15:06","pubTimestamp":1777273611,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，交银国际发布研报称，恒瑞医药首季业绩延续去年的高增长态势，创新药尤其是非肿瘤产品快速放量，在整体产品销售中的比例超过60%，创新转型已基本成功。基于首季业绩表现，交银国际上调恒瑞医药2026至2028年利润率预测，上调净利润预测3%至4%，并认为公司当前估值合理，上调目标价至74港元，维持“中性”评级。报告指，恒瑞医药首季收入/扣非净利润分别增长13%/17%，整体业绩略超该行此前的预期。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434303.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600276","01276","EWH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630847355","title":"创新成果持续落地、国际化再迎里程碑，挖掘恒瑞医药(01276)一季报背后的投资确定性","url":"https://stock-news.laohu8.com/highlight/detail?id=2630847355","media":"智通财经","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630847355?lang=zh_cn&edition=full","pubTime":"2026-04-27 10:28","pubTimestamp":1777256930,"startTime":"0","endTime":"0","summary":"4月22日晚，恒瑞医药正式发布了2026年第一季度经营业绩。而在临床研发方面，恒瑞医药今年一季度累计取得临床试验批准通知26个;2026年以来获得CDE突破性治疗品种认定6项。报告期内，公司创新药对外许可业务确认收入7.87亿元，主要系GSK确认的收入。近期，恒瑞医药国际化发展迎来新的里程碑。此前，Kailera公司已向恒瑞医药支付了1亿美元不可退还首付款。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1434202.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU2580892862.HKD","LU2097828805.USD","LU1328615791.USD","BK1191","LU1580142542.USD","LU1969619763.USD","LU1064130708.USD","LU2580892789.USD","LU2289578879.USD","01276","LU2495084118.USD","LU1781817850.SGD","LU1997244956.HKD","BK0183","BK0196","LU0405327494.USD","LU1064131003.USD","LU1997245177.USD","LU1997245094.SGD","LU0405327148.USD","LU2148510915.USD","BK0060","LU2097828631.EUR","LU0359201612.USD","BK0028","LU2328871848.SGD","BK0239","LU1820825898.SGD","LU2097828714.EUR","LU1655091616.SGD","600276","LU0359202008.SGD","LU2543165471.USD","BK0188","BK0012","LU1255011170.USD","LU0359201885.HKD","LU2488822045.USD","LU1146622755.USD","LU2097828557.USD","LU1023057109.AUD","LU2097828474.EUR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630879944","title":"花旗：恒瑞医药给予“买入”评级 目标价134港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2630879944","media":"新浪港股","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630879944?lang=zh_cn&edition=full","pubTime":"2026-04-25 10:15","pubTimestamp":1777083300,"startTime":"0","endTime":"0","summary":"　　花旗发布研报称，给予恒瑞医药H股目标价134港元以及“买入”评级。花旗指出，恒瑞医药2026年第一季创新药销售年增26%至45亿元人民币，占产品销售比重由去年同期的54%提升至62%。　　公司管理层重申2026年创新药销售年增超过30%的目标，并指出3月医院准入加速，为全年销售增长奠定基础。公司2026年第一季确认来自葛兰素史克合作的BD收入7.87亿元人民币，全年预计约2.5亿元人民币。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/hkstock/hkgg/2026-04-25/doc-inhvsqpe7283823.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["EWH","600276","01276"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2629950788","title":"瑞银：升恒瑞医药(01276)目标价至97.4港元 维持“买入”评级","url":"https://stock-news.laohu8.com/highlight/detail?id=2629950788","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2629950788?lang=zh_cn&edition=full","pubTime":"2026-04-24 10:54","pubTimestamp":1776999295,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，瑞银发布研报称，基于2026年第一季业绩，由于研发进展，上调恒瑞医药(01276)长期销售预测。目标价由91港元升至97.4港元，维持“买入”评级。恒瑞医药首季营收同比增13%至81.4亿元人民币，略低于市场预测85.3亿元人民币及该行预测88.1亿元人民币;净利润增长21.8%至22.8亿元人民币，大致符合市场预测21.8亿元人民币及该行预测23.3亿元人民币。第一季毛利率同比增1.4个百分点至86.6%; 净利润率上升2个百分点至28%。第一季研发投资达22.2亿人民币，其中16.5亿元人民币计入费用;销售费用率下降0.3个百分点至27%。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1433204.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["600276","EWH","01276"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.hrs.com.cn","stockEarnings":[{"period":"1week","weight":-0.02},{"period":"1month","weight":-0.0181},{"period":"3month","weight":-0.0429},{"period":"6month","weight":-0.0769},{"period":"1year","weight":0.4994},{"period":"ytd","weight":-0.0697}],"compareEarnings":[{"period":"1week","weight":0.0119},{"period":"1month","weight":0.0198},{"period":"3month","weight":-0.0286},{"period":"6month","weight":-0.0192},{"period":"1year","weight":0.1548},{"period":"ytd","weight":0.0303}],"compareStock":{"symbol":"HSI","name":"恒生指数"},"description":"江苏恒瑞医药股份有限公司是一家主要从事药品的研发、生产和销售的中国公司。该公司专注于肿瘤领域，覆盖激酶抑制剂、抗体偶联药物（ADC）、肿瘤免疫、激素受体调控、脱氧核糖核酸（DNA）修复及表观遗传、支持治疗等研究领域。该公司的产品包括抗肿瘤、镇痛麻醉和造影剂，应用于自身免疫疾病、代谢性疾病、心血管疾病、感染疾病、呼吸系统疾病、血液疾病、疼痛管理、神经系统疾病、眼科、肾病等领域。该公司主要在国内外市场开展其业务。","exchange":"SEHK","name":"恒瑞医药","nameEN":"HENGRUI PHARMA"},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.2","shortVersion":"4.42.2","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"恒瑞医药(01276)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供恒瑞医药(01276)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"恒瑞医药,01276,恒瑞医药股票,恒瑞医药股票老虎,恒瑞医药股票老虎国际,恒瑞医药行情,恒瑞医药股票行情,恒瑞医药股价,恒瑞医药股市,恒瑞医药股票价格,恒瑞医药股票交易,恒瑞医药股票购买,恒瑞医药股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"恒瑞医药(01276)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供恒瑞医药(01276)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}